Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model ; volume:13 ; number:1 ; day:25 ; month:3 ; year:2015 ; pages:1-12 ; date:12.2015
Journal of nanobiotechnology ; 13, Heft 1 (25.3.2015), 1-12, 12.2015
- Creator
-
Noorani, Lubna
Stenzel, Martina
Liang, Roger
Pourgholami, Mohammad H.
Morris, David L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-015-0082-8
- URN
-
urn:nbn:de:101:1-2021082019085661833166
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Noorani, Lubna
- Stenzel, Martina
- Liang, Roger
- Pourgholami, Mohammad H.
- Morris, David L.
- SpringerLink (Online service)
Other Objects (12)
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
Hyperacute xenograft rejection
Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue
Ischemia modified albumin increase indicating cardiac damage after experimental subarachnoid hemorrhage
Zinc Oxide Nanoparticles Promise Anticancer and Antibacterial Activity in Ovarian Cancer
Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
Hyperacute xenograft rejection
Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue
Ischemia modified albumin increase indicating cardiac damage after experimental subarachnoid hemorrhage
Zinc Oxide Nanoparticles Promise Anticancer and Antibacterial Activity in Ovarian Cancer
Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
Hyperacute xenograft rejection
Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue
Ischemia modified albumin increase indicating cardiac damage after experimental subarachnoid hemorrhage
Zinc Oxide Nanoparticles Promise Anticancer and Antibacterial Activity in Ovarian Cancer